Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies

v3.10.0.1
Commitments and Contingencies
9 Months Ended
Sep. 30, 2018
Commitments And Contingencies Disclosure [Abstract]  
Commitments and Contingencies

8. Commitments and contingencies

Leases and non-cancelable contractual obligations

The Company leases its facilities and certain equipment under operating leases that expire through September 2024. As of September 30, 2018, the minimum aggregate payments due under operating leases and specified non-cancelable contractual obligations, which consist of software license and maintenance agreements, are summarized as follows:

 

 

 

Operating leases

 

 

Related party

leases

 

 

Non-cancelable

contractual

obligations

 

 

Total

 

Remaining 3 months of 2018

 

$

546

 

 

$

8

 

 

$

144

 

 

$

698

 

2019

 

 

2,450

 

 

 

31

 

 

 

578

 

 

 

3,059

 

2020

 

 

2,212

 

 

 

10

 

 

 

578

 

 

 

2,800

 

2021

 

 

1,593

 

 

 

 

 

 

457

 

 

 

2,050

 

2022

 

 

1,273

 

 

 

 

 

 

 

 

 

1,273

 

Thereafter

 

 

2,132

 

 

 

 

 

 

 

 

 

2,132

 

 

 

$

10,206

 

 

$

49

 

 

$

1,757

 

 

$

12,012

 

 

As a result of the MedSupport acquisition, the Company leases a property owned by a related party.  Rent expense for the property was $8 and $24 for the three and nine months ended September 30, 2018, respectively.

 

Rent expense of $453 and $289 for the three months ended September 30, 2018 and September 30, 2017, respectively, and $1,183 and $829 for the nine months ended September 30, 2018 and September 30, 2017, respectively, was included in the accompanying consolidated statements of comprehensive income.

 

Purchase obligations

The Company had approximately $61,600 of outstanding purchase orders with its outside vendors and suppliers as of September 30, 2018.

Warranty obligations

Accruals for estimated standard warranty expenses are made at the time that the associated revenue is recognized. The provisions for estimated warranty obligations are made based on known claims and estimates of additional returns and warranty obligations based on historical data and future expectations. The following table identifies the changes in the Company’s aggregate product warranty liabilities for the nine and twelve-month periods ended September 30, 2018 and December 31, 2017, respectively:

 

 

 

September 30,

 

 

December 31,

 

 

 

2018

 

 

2017

 

Product warranty liability at beginning of period

 

$

6,171

 

 

$

3,480

 

Accruals for warranties issued

 

 

5,992

 

 

 

5,275

 

Adjustments related to preexisting warranties (including changes in estimates)

 

 

200

 

 

 

200

 

Settlements made (in cash or in kind)

 

 

(3,121

)

 

 

(2,784

)

Product warranty liability at end of period

 

$

9,242

 

 

$

6,171

 

 

Legislation and HIPAA

The healthcare industry is subject to numerous laws and regulations of federal, state and local governments. These laws and regulations include, but are not necessarily limited to, matters such as licensure, accreditation, government healthcare program participation requirements, reimbursement for patient services, and Medicare and Medicaid fraud and abuse. Government activity has continued with respect to investigations and allegations concerning possible violations of fraud and abuse statutes and regulations by healthcare providers. Violations of these laws and regulations could result in exclusion from government healthcare programs together with the imposition of significant fines and penalties, as well as significant repayments for patient services previously billed.

The Company believes that it is in compliance in all material respects with applicable fraud and abuse regulations and other applicable government laws and regulations. Compliance with such laws and regulations can be subject to future government review and interpretation as well as regulatory actions unknown or unasserted at this time.

The Health Insurance Portability and Accountability Act of 1996 (HIPAA) ensures health insurance portability, reduces healthcare fraud and abuse, guarantees security and privacy of health information, and enforces standards for health information. The Health Information Technology for Economic and Clinical Health Act (HITECH Act) imposes notification requirements of certain security breaches relating to protected health information. The Company believes it complies in all material respects with the provisions of those regulations that are applicable to the Company’s business.

Legal proceedings

The Company is party to various legal proceedings arising in the normal course of business. The Company carries insurance, subject to specified deductibles under the policies, to protect against losses from certain liabilities and costs. At this time, the Company does not anticipate that any of these other proceedings will have a material adverse effect on the Company’s business. Regardless of the outcome, litigation can have an adverse impact on the Company because of defense and settlement costs, diversion of management resources, and other factors.